165 related articles for article (PubMed ID: 16218463)
1. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?
Toubi E; Shoenfeld Y
Lupus; 2005; 14(9):665-9. PubMed ID: 16218463
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
3. Vaccination for atherosclerosis: a novel therapeutic paradigm.
Shah PK; Chyu KY; Fredrikson GN; Nilsson J
Expert Rev Vaccines; 2004 Dec; 3(6):711-6. PubMed ID: 15606356
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis: immunopathogenesis and immunotherapy.
Ohashi R; Mu H; Yao Q; Chen C
Med Sci Monit; 2004 Nov; 10(11):RA255-60. PubMed ID: 15507866
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity.
Cinoku II; Mavragani CP; Moutsopoulos HM
Eur J Clin Invest; 2020 Feb; 50(2):e13195. PubMed ID: 31868918
[TBL] [Abstract][Full Text] [Related]
6. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
[TBL] [Abstract][Full Text] [Related]
7. Vaccination to modulate atherosclerosis.
Kimura T; Tse K; Sette A; Ley K
Autoimmunity; 2015 May; 48(3):152-60. PubMed ID: 25683179
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
Stoll G; Bendszus M
Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity, infectious immunity, and atherosclerosis.
Matsuura E; Kobayashi K; Matsunami Y; Shen L; Quan N; Makarova M; Suchkov SV; Ayada K; Oguma K; Lopez LR
J Clin Immunol; 2009 Nov; 29(6):714-21. PubMed ID: 19795194
[TBL] [Abstract][Full Text] [Related]
10. 2nd conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005.
Doria A; Sarzi-Puttini P; Shoenfeld Y
Autoimmun Rev; 2006 Jan; 5(1):55-63. PubMed ID: 16338212
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
Nilsson J; Wigren M; Shah PK
Trends Cardiovasc Med; 2009 Nov; 19(8):272-6. PubMed ID: 20447570
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease.
Suthers B; Hansbro P; Thambar S; McEvoy M; Peel R; Attia J
Vaccine; 2012 Jun; 30(27):3983-5. PubMed ID: 22507657
[TBL] [Abstract][Full Text] [Related]
13. Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders.
Suciu CF; Prete M; Ruscitti P; Favoino E; Giacomelli R; Perosa F
Autoimmun Rev; 2018 Apr; 17(4):366-375. PubMed ID: 29425936
[TBL] [Abstract][Full Text] [Related]
14. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
15. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
Frostegård J
Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
[TBL] [Abstract][Full Text] [Related]
16. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
17. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
Habets KL; van Puijvelde GH; van Duivenvoorde LM; van Wanrooij EJ; de Vos P; Tervaert JW; van Berkel TJ; Toes RE; Kuiper J
Cardiovasc Res; 2010 Feb; 85(3):622-30. PubMed ID: 19819882
[TBL] [Abstract][Full Text] [Related]
18. The role of immune complexes in atherogenesis.
Burut DF; Karim Y; Ferns GA
Angiology; 2010 Oct; 61(7):679-89. PubMed ID: 20395232
[TBL] [Abstract][Full Text] [Related]
19. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
20. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Satta N; Frias MA; Vuilleumier N; Pagano S
Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
